

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 8.15894766 |
| 2 | ensheathment of neurons (GO:0007272) | 7.20573937 |
| 3 | axon ensheathment (GO:0008366) | 7.20573937 |
| 4 | myelination (GO:0042552) | 7.18360801 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.44048855 |
| 6 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.99483793 |
| 7 | glutamate secretion (GO:0014047) | 5.98204530 |
| 8 | synaptic vesicle maturation (GO:0016188) | 5.65930917 |
| 9 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.32028881 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 5.31998198 |
| 11 | cholesterol biosynthetic process (GO:0006695) | 5.16925214 |
| 12 | myelin maintenance (GO:0043217) | 5.08446813 |
| 13 | cellular potassium ion homeostasis (GO:0030007) | 4.98029958 |
| 14 | sodium ion export (GO:0071436) | 4.96660696 |
| 15 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.92126758 |
| 16 | oligodendrocyte differentiation (GO:0048709) | 4.77683991 |
| 17 | negative regulation of neurotransmitter transport (GO:0051589) | 4.71996689 |
| 18 | glycerophospholipid catabolic process (GO:0046475) | 4.68122100 |
| 19 | creatine metabolic process (GO:0006600) | 4.66970020 |
| 20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.57590033 |
| 21 | positive regulation of synapse maturation (GO:0090129) | 4.56018963 |
| 22 | sterol biosynthetic process (GO:0016126) | 4.52494563 |
| 23 | regulation of collateral sprouting (GO:0048670) | 4.40930158 |
| 24 | substantia nigra development (GO:0021762) | 4.34732739 |
| 25 | establishment of mitochondrion localization (GO:0051654) | 4.32604925 |
| 26 | negative regulation of protein localization to cell surface (GO:2000009) | 4.32541535 |
| 27 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.27751821 |
| 28 | eye photoreceptor cell differentiation (GO:0001754) | 4.24203822 |
| 29 | photoreceptor cell differentiation (GO:0046530) | 4.24203822 |
| 30 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.20237253 |
| 31 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.17516525 |
| 32 | astrocyte development (GO:0014002) | 4.13232727 |
| 33 | presynaptic membrane organization (GO:0097090) | 4.11108727 |
| 34 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 4.08224958 |
| 35 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.06362765 |
| 36 | apical protein localization (GO:0045176) | 4.04797403 |
| 37 | L-amino acid import (GO:0043092) | 4.04563180 |
| 38 | asymmetric protein localization (GO:0008105) | 3.98711401 |
| 39 | amyloid precursor protein metabolic process (GO:0042982) | 3.97762317 |
| 40 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.94380713 |
| 41 | neurotransmitter secretion (GO:0007269) | 3.93002487 |
| 42 | response to methylmercury (GO:0051597) | 3.91377017 |
| 43 | response to redox state (GO:0051775) | 3.88537475 |
| 44 | presynaptic membrane assembly (GO:0097105) | 3.87719352 |
| 45 | virion attachment to host cell (GO:0019062) | 3.87072538 |
| 46 | adhesion of symbiont to host cell (GO:0044650) | 3.87072538 |
| 47 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.86669376 |
| 48 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.84710111 |
| 49 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.84487187 |
| 50 | regulation of synaptic vesicle transport (GO:1902803) | 3.83162085 |
| 51 | isoprenoid biosynthetic process (GO:0008299) | 3.80876375 |
| 52 | import into cell (GO:0098657) | 3.78415200 |
| 53 | peripheral nervous system axon ensheathment (GO:0032292) | 3.77695371 |
| 54 | myelination in peripheral nervous system (GO:0022011) | 3.77695371 |
| 55 | potassium ion homeostasis (GO:0055075) | 3.75198873 |
| 56 | vocalization behavior (GO:0071625) | 3.72553328 |
| 57 | response to lipoprotein particle (GO:0055094) | 3.70633517 |
| 58 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.67476774 |
| 59 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.62188252 |
| 60 | regulation of synapse maturation (GO:0090128) | 3.47424635 |
| 61 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.46316620 |
| 62 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.41671602 |
| 63 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.39873141 |
| 64 | protein palmitoylation (GO:0018345) | 3.39403577 |
| 65 | positive regulation of dendritic spine development (GO:0060999) | 3.38051745 |
| 66 | adult walking behavior (GO:0007628) | 3.36275158 |
| 67 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.34723272 |
| 68 | acidic amino acid transport (GO:0015800) | 3.34099889 |
| 69 | membrane tubulation (GO:0097320) | 3.32420286 |
| 70 | negative regulation of axonogenesis (GO:0050771) | 3.32098250 |
| 71 | transmission of nerve impulse (GO:0019226) | 3.30741497 |
| 72 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.28159388 |
| 73 | magnesium ion transport (GO:0015693) | 3.26982062 |
| 74 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.25886960 |
| 75 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.25577628 |
| 76 | regulation of ARF protein signal transduction (GO:0032012) | 3.24905115 |
| 77 | regulation of synaptic plasticity (GO:0048167) | 3.24475496 |
| 78 | glycosylceramide metabolic process (GO:0006677) | 3.23455209 |
| 79 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.21157034 |
| 80 | regulation of synapse structural plasticity (GO:0051823) | 3.19218236 |
| 81 | potassium ion import (GO:0010107) | 3.19149285 |
| 82 | locomotory exploration behavior (GO:0035641) | 3.19021204 |
| 83 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.17345376 |
| 84 | very long-chain fatty acid metabolic process (GO:0000038) | 3.15679201 |
| 85 | negative regulation of inclusion body assembly (GO:0090084) | 3.14666788 |
| 86 | neuromuscular process controlling balance (GO:0050885) | 3.13498363 |
| 87 | neuronal ion channel clustering (GO:0045161) | 3.13391575 |
| 88 | neurotransmitter transport (GO:0006836) | 3.13037585 |
| 89 | L-glutamate transport (GO:0015813) | 3.10081964 |
| 90 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.09650219 |
| 91 | layer formation in cerebral cortex (GO:0021819) | 3.08362182 |
| 92 | neuron remodeling (GO:0016322) | 3.07653114 |
| 93 | cellular response to epinephrine stimulus (GO:0071872) | 3.07286782 |
| 94 | positive regulation of action potential (GO:0045760) | 3.06401341 |
| 95 | amyloid precursor protein catabolic process (GO:0042987) | 3.06112836 |
| 96 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.04324858 |
| 97 | peripheral nervous system development (GO:0007422) | 3.02790282 |
| 98 | regulation of ARF GTPase activity (GO:0032312) | 3.00351827 |
| 99 | neuron cell-cell adhesion (GO:0007158) | 2.99250836 |
| 100 | axon development (GO:0061564) | 2.98173120 |
| 101 | limb bud formation (GO:0060174) | 2.97294708 |
| 102 | acyl-CoA biosynthetic process (GO:0071616) | 2.96942649 |
| 103 | thioester biosynthetic process (GO:0035384) | 2.96942649 |
| 104 | synaptic vesicle endocytosis (GO:0048488) | 2.94375382 |
| 105 | GPI anchor biosynthetic process (GO:0006506) | 2.93373788 |
| 106 | peptidyl-cysteine modification (GO:0018198) | 2.92711677 |
| 107 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.91984638 |
| 108 | GPI anchor metabolic process (GO:0006505) | 2.89822426 |
| 109 | nerve growth factor signaling pathway (GO:0038180) | 2.89595912 |
| 110 | neural nucleus development (GO:0048857) | 2.89269135 |
| 111 | cell communication by electrical coupling (GO:0010644) | 2.88914135 |
| 112 | amino acid import (GO:0043090) | 2.87390800 |
| 113 | negative regulation of JUN kinase activity (GO:0043508) | 2.86612541 |
| 114 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.86140708 |
| 115 | nucleotide transmembrane transport (GO:1901679) | 2.85650675 |
| 116 | neuronal action potential propagation (GO:0019227) | 2.85115718 |
| 117 | regulation of neurotransmitter levels (GO:0001505) | 2.84332892 |
| 118 | cellular sodium ion homeostasis (GO:0006883) | 2.82511245 |
| 119 | dicarboxylic acid transport (GO:0006835) | 2.82065647 |
| 120 | adhesion of symbiont to host (GO:0044406) | 2.81897316 |
| 121 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.81563845 |
| 122 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.81135188 |
| 123 | regulation of lipoprotein metabolic process (GO:0050746) | 2.80588998 |
| 124 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.79417008 |
| 125 | negative regulation of axon extension (GO:0030517) | 2.78210741 |
| 126 | glial cell development (GO:0021782) | 2.76583368 |
| 127 | postsynaptic membrane organization (GO:0001941) | 2.76094115 |
| 128 | synaptic transmission, glutamatergic (GO:0035249) | 2.75529931 |
| 129 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.73741229 |
| 130 | positive regulation of glial cell differentiation (GO:0045687) | 2.72957456 |
| 131 | response to epinephrine (GO:0071871) | 2.72824126 |
| 132 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.72460311 |
| 133 | positive regulation of neurotransmitter transport (GO:0051590) | 2.71338927 |
| 134 | regulation of neurotransmitter secretion (GO:0046928) | 2.70269176 |
| 135 | dendritic spine organization (GO:0097061) | 2.68637218 |
| 136 | dopamine receptor signaling pathway (GO:0007212) | 2.68486679 |
| 137 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.67837284 |
| 138 | positive regulation of dendrite development (GO:1900006) | 2.67531122 |
| 139 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.67497207 |
| 140 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.65654856 |
| 141 | activation of protein kinase A activity (GO:0034199) | 2.64225419 |
| 142 | positive regulation of membrane potential (GO:0045838) | 2.63638054 |
| 143 | exploration behavior (GO:0035640) | 2.63591156 |
| 144 | long-term memory (GO:0007616) | 2.63260760 |
| 145 | adenosine receptor signaling pathway (GO:0001973) | 2.63122699 |
| 146 | iron coordination entity transport (GO:1901678) | 2.60634473 |
| 147 | cerebellar granule cell differentiation (GO:0021707) | 2.60475355 |
| 148 | cellular response to monoamine stimulus (GO:0071868) | 2.60273293 |
| 149 | cellular response to catecholamine stimulus (GO:0071870) | 2.60273293 |
| 150 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.60178185 |
| 151 | response to hepatocyte growth factor (GO:0035728) | 2.60178185 |
| 152 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.58927926 |
| 153 | cell migration in hindbrain (GO:0021535) | 2.58532351 |
| 154 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.58416878 |
| 155 | positive regulation of gliogenesis (GO:0014015) | 2.58212410 |
| 156 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.57917742 |
| 157 | activation of Rac GTPase activity (GO:0032863) | 2.57890268 |
| 158 | neuron-neuron synaptic transmission (GO:0007270) | 2.56866621 |
| 159 | glial cell differentiation (GO:0010001) | 2.56786970 |
| 160 | protein targeting to plasma membrane (GO:0072661) | 2.55562128 |
| 161 | enteric nervous system development (GO:0048484) | 2.55031288 |
| 162 | organ growth (GO:0035265) | 2.53487163 |
| 163 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.52985297 |
| 164 | cell volume homeostasis (GO:0006884) | 2.51823628 |
| 165 | long term synaptic depression (GO:0060292) | 2.51139104 |
| 166 | neurotransmitter uptake (GO:0001504) | 2.50474754 |
| 167 | protein localization to synapse (GO:0035418) | 2.50200921 |
| 168 | heme transport (GO:0015886) | 2.48774260 |
| 169 | regulation of dendritic spine development (GO:0060998) | 2.47848964 |
| 170 | membrane assembly (GO:0071709) | 2.47410055 |
| 171 | negative regulation of macroautophagy (GO:0016242) | 2.47402681 |
| 172 | ceramide biosynthetic process (GO:0046513) | 2.46765653 |
| 173 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.46081229 |
| 174 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.46081229 |
| 175 | long-term synaptic potentiation (GO:0060291) | 2.45902137 |
| 176 | regulation of vesicle fusion (GO:0031338) | 2.45565373 |
| 177 | regulation of sensory perception (GO:0051931) | 2.44526872 |
| 178 | regulation of sensory perception of pain (GO:0051930) | 2.44526872 |
| 179 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.43102286 |
| 180 | regulation of neurotransmitter transport (GO:0051588) | 2.41920944 |
| 181 | regulation of inclusion body assembly (GO:0090083) | 2.40059581 |
| 182 | positive regulation of Rap GTPase activity (GO:0032854) | 2.39838292 |
| 183 | regulation of synaptic transmission (GO:0050804) | 2.37865440 |
| 184 | central nervous system myelination (GO:0022010) | 11.5431574 |
| 185 | axon ensheathment in central nervous system (GO:0032291) | 11.5431574 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.51589423 |
| 2 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.23511022 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.22802827 |
| 4 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 3.01582035 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.83143540 |
| 6 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.81046223 |
| 7 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.75998193 |
| 8 | KDM2B_26808549_Chip-Seq_K562_Human | 2.49502479 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.35270663 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.34993027 |
| 11 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.34415132 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.34106496 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.28065979 |
| 14 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.27701783 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.23018418 |
| 16 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.19155989 |
| 17 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.17417719 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.17099439 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.15106306 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.11907295 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.08914227 |
| 22 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.07780903 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.05591610 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.05371627 |
| 25 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 2.01611785 |
| 26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.01075439 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.01075439 |
| 28 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 2.00886410 |
| 29 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.98799697 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.96612635 |
| 31 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.95617126 |
| 32 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.95126058 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.88290976 |
| 34 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.87295297 |
| 35 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.86543155 |
| 36 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.85386904 |
| 37 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.85130573 |
| 38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.84280668 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.83934453 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.81227215 |
| 41 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.80371722 |
| 42 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.79210620 |
| 43 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.72416038 |
| 44 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.71924163 |
| 45 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.70523755 |
| 46 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68344023 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.67852184 |
| 48 | P68_20966046_ChIP-Seq_HELA_Human | 1.67137832 |
| 49 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.65028544 |
| 50 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.65018395 |
| 51 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64456528 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.63787976 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.61340109 |
| 54 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.60413327 |
| 55 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.59714185 |
| 56 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.58605132 |
| 57 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.57468482 |
| 58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56737880 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56262191 |
| 60 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.56009127 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.51879493 |
| 62 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49596504 |
| 63 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.46615541 |
| 64 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.46442747 |
| 65 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.46334686 |
| 66 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.46036488 |
| 67 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.43017828 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.42303976 |
| 69 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.41941801 |
| 70 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.41546153 |
| 71 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41524948 |
| 72 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.41140349 |
| 73 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.40555368 |
| 74 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.40109464 |
| 75 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.40031566 |
| 76 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38161968 |
| 77 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.37662597 |
| 78 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.35837099 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.35396349 |
| 80 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.34896980 |
| 81 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.31604310 |
| 82 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.31228503 |
| 83 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.30680449 |
| 84 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.30260584 |
| 85 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29327074 |
| 86 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.26732725 |
| 87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26289364 |
| 88 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.26060212 |
| 89 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23707012 |
| 90 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.22693632 |
| 91 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.21738790 |
| 92 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21215375 |
| 93 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.20999296 |
| 94 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.18685272 |
| 95 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.17711770 |
| 96 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.16895230 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16851586 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16840768 |
| 99 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16272826 |
| 100 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.15931493 |
| 101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.15931493 |
| 102 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15872020 |
| 103 | FUS_26573619_Chip-Seq_HEK293_Human | 1.15724963 |
| 104 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.14571203 |
| 105 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.13084487 |
| 106 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12426992 |
| 107 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.11520092 |
| 108 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.11260406 |
| 109 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.10917549 |
| 110 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.10833817 |
| 111 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.10412532 |
| 112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10242527 |
| 113 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.08425756 |
| 114 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07860467 |
| 115 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07552982 |
| 116 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06891534 |
| 117 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06794351 |
| 118 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.06709092 |
| 119 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.06596875 |
| 120 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06293989 |
| 121 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05891174 |
| 122 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04962062 |
| 123 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04650955 |
| 124 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04530711 |
| 125 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04416163 |
| 126 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.03298992 |
| 127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01908607 |
| 128 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.01208968 |
| 129 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.00788792 |
| 130 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99727080 |
| 131 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99471523 |
| 132 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.99040536 |
| 133 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98710931 |
| 134 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.98459478 |
| 135 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.98064157 |
| 136 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97305914 |
| 137 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.97052324 |
| 138 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97009763 |
| 139 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.96876239 |
| 140 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95845908 |
| 141 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95572464 |
| 142 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94518244 |
| 143 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94072892 |
| 144 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93977356 |
| 145 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.93975332 |
| 146 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.93793363 |
| 147 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93492449 |
| 148 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93032506 |
| 149 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92596450 |
| 150 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90853832 |
| 151 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.90832407 |
| 152 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.90789391 |
| 153 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.90783732 |
| 154 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90224444 |
| 155 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89321099 |
| 156 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89170401 |
| 157 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.88945389 |
| 158 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.88701513 |
| 159 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88473358 |
| 160 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.88420019 |
| 161 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.88299493 |
| 162 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88082027 |
| 163 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88035267 |
| 164 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.87301253 |
| 165 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86919627 |
| 166 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86752906 |
| 167 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85426191 |
| 168 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.85310622 |
| 169 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.84966784 |
| 170 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84815802 |
| 171 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.84689714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0000920_abnormal_myelination | 5.49638669 |
| 2 | MP0003880_abnormal_central_pattern | 4.08004768 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.82084320 |
| 4 | MP0004270_analgesia | 3.50348826 |
| 5 | MP0003690_abnormal_glial_cell | 3.43995660 |
| 6 | MP0003329_amyloid_beta_deposits | 2.84325957 |
| 7 | MP0001529_abnormal_vocalization | 2.80859359 |
| 8 | MP0004885_abnormal_endolymph | 2.73621142 |
| 9 | MP0004742_abnormal_vestibular_system | 2.61574256 |
| 10 | MP0005171_absent_coat_pigmentation | 2.59169387 |
| 11 | MP0002272_abnormal_nervous_system | 2.58743392 |
| 12 | MP0001905_abnormal_dopamine_level | 2.51013602 |
| 13 | MP0001486_abnormal_startle_reflex | 2.46298236 |
| 14 | MP0003634_abnormal_glial_cell | 2.45661394 |
| 15 | MP0004859_abnormal_synaptic_plasticity | 2.43808500 |
| 16 | MP0003879_abnormal_hair_cell | 2.37624828 |
| 17 | MP0003136_yellow_coat_color | 2.28965879 |
| 18 | MP0002064_seizures | 2.26940025 |
| 19 | MP0004142_abnormal_muscle_tone | 2.25280039 |
| 20 | MP0005409_darkened_coat_color | 2.24149435 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 2.23143633 |
| 22 | MP0001485_abnormal_pinna_reflex | 2.22839159 |
| 23 | MP0000778_abnormal_nervous_system | 2.18947953 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 2.15637498 |
| 25 | MP0003632_abnormal_nervous_system | 1.99501847 |
| 26 | MP0005451_abnormal_body_composition | 1.98086369 |
| 27 | MP0005410_abnormal_fertilization | 1.85410120 |
| 28 | MP0000462_abnormal_digestive_system | 1.85000692 |
| 29 | MP0005423_abnormal_somatic_nervous | 1.83042118 |
| 30 | MP0009046_muscle_twitch | 1.82932182 |
| 31 | * MP0002229_neurodegeneration | 1.81184061 |
| 32 | MP0010678_abnormal_skin_adnexa | 1.77285122 |
| 33 | MP0003635_abnormal_synaptic_transmissio | 1.76956985 |
| 34 | MP0009745_abnormal_behavioral_response | 1.76732936 |
| 35 | MP0000383_abnormal_hair_follicle | 1.72998417 |
| 36 | MP0002734_abnormal_mechanical_nocicepti | 1.72411377 |
| 37 | MP0003123_paternal_imprinting | 1.68095082 |
| 38 | MP0010234_abnormal_vibrissa_follicle | 1.58111635 |
| 39 | MP0004381_abnormal_hair_follicle | 1.53829180 |
| 40 | MP0000955_abnormal_spinal_cord | 1.53508020 |
| 41 | MP0004043_abnormal_pH_regulation | 1.52155887 |
| 42 | MP0000604_amyloidosis | 1.47534809 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.46726568 |
| 44 | MP0003631_nervous_system_phenotype | 1.44515954 |
| 45 | MP0004134_abnormal_chest_morphology | 1.44288417 |
| 46 | MP0003195_calcinosis | 1.43684519 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.41027595 |
| 48 | MP0002882_abnormal_neuron_morphology | 1.40624319 |
| 49 | MP0001440_abnormal_grooming_behavior | 1.37749078 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.35866550 |
| 51 | MP0002572_abnormal_emotion/affect_behav | 1.33324972 |
| 52 | MP0002249_abnormal_larynx_morphology | 1.32321380 |
| 53 | MP0002066_abnormal_motor_capabilities/c | 1.29520970 |
| 54 | MP0008569_lethality_at_weaning | 1.26407346 |
| 55 | MP0002063_abnormal_learning/memory/cond | 1.25780701 |
| 56 | MP0004147_increased_porphyrin_level | 1.23168064 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.23000468 |
| 58 | MP0005386_behavior/neurological_phenoty | 1.22907179 |
| 59 | MP0004924_abnormal_behavior | 1.22907179 |
| 60 | MP0001346_abnormal_lacrimal_gland | 1.22261946 |
| 61 | MP0000747_muscle_weakness | 1.22019668 |
| 62 | MP0008874_decreased_physiological_sensi | 1.21817738 |
| 63 | MP0001958_emphysema | 1.21382919 |
| 64 | MP0003633_abnormal_nervous_system | 1.18544555 |
| 65 | MP0002067_abnormal_sensory_capabilities | 1.16786079 |
| 66 | MP0001963_abnormal_hearing_physiology | 1.14852841 |
| 67 | MP0001970_abnormal_pain_threshold | 1.14750295 |
| 68 | MP0002752_abnormal_somatic_nervous | 1.14279520 |
| 69 | MP0005623_abnormal_meninges_morphology | 1.10899769 |
| 70 | MP0008260_abnormal_autophagy | 1.10792035 |
| 71 | MP0003075_altered_response_to | 1.09367943 |
| 72 | MP0000647_abnormal_sebaceous_gland | 1.01978897 |
| 73 | MP0002733_abnormal_thermal_nociception | 1.00239132 |
| 74 | MP0001299_abnormal_eye_distance/ | 0.98431572 |
| 75 | MP0003283_abnormal_digestive_organ | 0.97767634 |
| 76 | MP0005408_hypopigmentation | 0.94565184 |
| 77 | MP0005670_abnormal_white_adipose | 0.94405618 |
| 78 | MP0001851_eye_inflammation | 0.93674880 |
| 79 | MP0005195_abnormal_posterior_eye | 0.93321676 |
| 80 | MP0000566_synostosis | 0.92126618 |
| 81 | MP0002295_abnormal_pulmonary_circulatio | 0.91982460 |
| 82 | MP0003938_abnormal_ear_development | 0.91806762 |
| 83 | MP0005076_abnormal_cell_differentiation | 0.91102178 |
| 84 | MP0005058_abnormal_lysosome_morphology | 0.90966571 |
| 85 | MP0000003_abnormal_adipose_tissue | 0.90575089 |
| 86 | MP0002089_abnormal_postnatal_growth/wei | 0.89445646 |
| 87 | MP0000751_myopathy | 0.87160722 |
| 88 | MP0001984_abnormal_olfaction | 0.86560636 |
| 89 | MP0001177_atelectasis | 0.85518644 |
| 90 | MP0001661_extended_life_span | 0.85389455 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.85180922 |
| 92 | MP0000762_abnormal_tongue_morphology | 0.80372432 |
| 93 | MP0003787_abnormal_imprinting | 0.79954737 |
| 94 | * MP0002152_abnormal_brain_morphology | 0.79043825 |
| 95 | MP0004145_abnormal_muscle_electrophysio | 0.78754491 |
| 96 | MP0008438_abnormal_cutaneous_collagen | 0.78452455 |
| 97 | MP0001348_abnormal_lacrimal_gland | 0.78110427 |
| 98 | MP0002822_catalepsy | 0.77624417 |
| 99 | MP0003937_abnormal_limbs/digits/tail_de | 0.76429756 |
| 100 | MP0001968_abnormal_touch/_nociception | 0.75676579 |
| 101 | MP0003279_aneurysm | 0.75484037 |
| 102 | MP0000026_abnormal_inner_ear | 0.74698594 |
| 103 | MP0002090_abnormal_vision | 0.74048523 |
| 104 | MP0002735_abnormal_chemical_nociception | 0.72175618 |
| 105 | MP0001849_ear_inflammation | 0.72067674 |
| 106 | MP0005253_abnormal_eye_physiology | 0.71693926 |
| 107 | MP0000579_abnormal_nail_morphology | 0.71278665 |
| 108 | MP0000467_abnormal_esophagus_morphology | 0.70517887 |
| 109 | MP0005275_abnormal_skin_tensile | 0.70180456 |
| 110 | MP0006072_abnormal_retinal_apoptosis | 0.69707699 |
| 111 | MP0004858_abnormal_nervous_system | 0.69119375 |
| 112 | MP0005375_adipose_tissue_phenotype | 0.68294771 |
| 113 | MP0003191_abnormal_cellular_cholesterol | 0.66617184 |
| 114 | MP0001501_abnormal_sleep_pattern | 0.66118935 |
| 115 | MP0001664_abnormal_digestion | 0.65677760 |
| 116 | MP0000678_abnormal_parathyroid_gland | 0.64961760 |
| 117 | MP0004185_abnormal_adipocyte_glucose | 0.64713084 |
| 118 | MP0004036_abnormal_muscle_relaxation | 0.64004387 |
| 119 | MP0000681_abnormal_thyroid_gland | 0.63342234 |
| 120 | MP0004130_abnormal_muscle_cell | 0.63312874 |
| 121 | MP0005595_abnormal_vascular_smooth | 0.63146947 |
| 122 | MP0002184_abnormal_innervation | 0.62153422 |
| 123 | MP0002909_abnormal_adrenal_gland | 0.62092895 |
| 124 | MP0005666_abnormal_adipose_tissue | 0.62035712 |
| 125 | MP0004811_abnormal_neuron_physiology | 0.62017098 |
| 126 | MP0010771_integument_phenotype | 0.61951661 |
| 127 | MP0004510_myositis | 0.61060812 |
| 128 | MP0001765_abnormal_ion_homeostasis | 0.60952507 |
| 129 | MP0001502_abnormal_circadian_rhythm | 0.60658280 |
| 130 | MP0009840_abnormal_foam_cell | 0.59141507 |
| 131 | MP0005535_abnormal_body_temperature | 0.59115503 |
| 132 | MP0006082_CNS_inflammation | 0.59068510 |
| 133 | MP0002060_abnormal_skin_morphology | 0.58987023 |
| 134 | MP0002736_abnormal_nociception_after | 0.57720165 |
| 135 | MP0003137_abnormal_impulse_conducting | 0.56204600 |
| 136 | MP0001727_abnormal_embryo_implantation | 0.55015451 |
| 137 | MP0001340_abnormal_eyelid_morphology | 0.54809133 |
| 138 | MP0002557_abnormal_social/conspecific_i | 0.54692323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.68188997 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.68188997 |
| 3 | Neurofibrillary tangles (HP:0002185) | 6.60528857 |
| 4 | Parakeratosis (HP:0001036) | 5.50165015 |
| 5 | Abnormality of the corticospinal tract (HP:0002492) | 4.97770254 |
| 6 | Peripheral hypomyelination (HP:0007182) | 4.83908097 |
| 7 | Cerebral inclusion bodies (HP:0100314) | 4.76178050 |
| 8 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.35583940 |
| 9 | Supranuclear gaze palsy (HP:0000605) | 4.09640201 |
| 10 | Onion bulb formation (HP:0003383) | 4.05446300 |
| 11 | Abnormality of binocular vision (HP:0011514) | 3.92471838 |
| 12 | Diplopia (HP:0000651) | 3.92471838 |
| 13 | Obstructive sleep apnea (HP:0002870) | 3.77151695 |
| 14 | Focal motor seizures (HP:0011153) | 3.65573410 |
| 15 | Insomnia (HP:0100785) | 3.59092276 |
| 16 | Alacrima (HP:0000522) | 3.50954777 |
| 17 | Abnormal auditory evoked potentials (HP:0006958) | 3.48862415 |
| 18 | Akinesia (HP:0002304) | 3.34854258 |
| 19 | Upper limb amyotrophy (HP:0009129) | 3.28163189 |
| 20 | Distal upper limb amyotrophy (HP:0007149) | 3.28163189 |
| 21 | Increased serum pyruvate (HP:0003542) | 3.27291697 |
| 22 | Abnormality of glycolysis (HP:0004366) | 3.27291697 |
| 23 | Hyperacusis (HP:0010780) | 3.20934888 |
| 24 | Annular pancreas (HP:0001734) | 3.18190763 |
| 25 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.17380933 |
| 26 | Focal seizures (HP:0007359) | 3.16116111 |
| 27 | Termporal pattern (HP:0011008) | 3.15415224 |
| 28 | Insidious onset (HP:0003587) | 3.15415224 |
| 29 | Epileptic encephalopathy (HP:0200134) | 3.14044341 |
| 30 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.10445246 |
| 31 | Visual hallucinations (HP:0002367) | 3.08737240 |
| 32 | Myokymia (HP:0002411) | 3.02593190 |
| 33 | Scanning speech (HP:0002168) | 3.00777288 |
| 34 | * Spastic gait (HP:0002064) | 2.98028167 |
| 35 | Retinal dysplasia (HP:0007973) | 2.92571706 |
| 36 | Ankle clonus (HP:0011448) | 2.87006458 |
| 37 | Lower limb amyotrophy (HP:0007210) | 2.81992441 |
| 38 | * Dysmetria (HP:0001310) | 2.80469075 |
| 39 | Cerebral hemorrhage (HP:0001342) | 2.72028465 |
| 40 | Decreased lacrimation (HP:0000633) | 2.68406703 |
| 41 | Clumsiness (HP:0002312) | 2.65462081 |
| 42 | Anteriorly placed anus (HP:0001545) | 2.64517877 |
| 43 | Stridor (HP:0010307) | 2.64125308 |
| 44 | Bronchomalacia (HP:0002780) | 2.63982859 |
| 45 | Premature skin wrinkling (HP:0100678) | 2.63661879 |
| 46 | Hypoplastic pelvis (HP:0008839) | 2.61620236 |
| 47 | Increased circulating renin level (HP:0000848) | 2.58593803 |
| 48 | Turricephaly (HP:0000262) | 2.53597576 |
| 49 | Thickened helices (HP:0000391) | 2.53405940 |
| 50 | Rapidly progressive (HP:0003678) | 2.53077061 |
| 51 | Distal lower limb amyotrophy (HP:0008944) | 2.48491707 |
| 52 | Ulnar bowing (HP:0003031) | 2.47664936 |
| 53 | * Leukodystrophy (HP:0002415) | 2.45851798 |
| 54 | Absent septum pellucidum (HP:0001331) | 2.45515446 |
| 55 | Morphological abnormality of the inner ear (HP:0011390) | 2.44976993 |
| 56 | Urinary urgency (HP:0000012) | 2.43292087 |
| 57 | Hand muscle atrophy (HP:0009130) | 2.42770035 |
| 58 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.42715585 |
| 59 | Autoamputation (HP:0001218) | 2.40519675 |
| 60 | * Intention tremor (HP:0002080) | 2.40144762 |
| 61 | Postural instability (HP:0002172) | 2.38620798 |
| 62 | Pheochromocytoma (HP:0002666) | 2.35719860 |
| 63 | Achilles tendon contracture (HP:0001771) | 2.35604016 |
| 64 | Febrile seizures (HP:0002373) | 2.34420130 |
| 65 | Cerebral aneurysm (HP:0004944) | 2.33365206 |
| 66 | Neuronal loss in central nervous system (HP:0002529) | 2.33331497 |
| 67 | Shallow orbits (HP:0000586) | 2.32941002 |
| 68 | * Cerebral hypomyelination (HP:0006808) | 2.32209353 |
| 69 | Protrusio acetabuli (HP:0003179) | 2.31854321 |
| 70 | Torticollis (HP:0000473) | 2.31692698 |
| 71 | Abnormality of the periventricular white matter (HP:0002518) | 2.31548844 |
| 72 | Coronal craniosynostosis (HP:0004440) | 2.28322066 |
| 73 | Methylmalonic acidemia (HP:0002912) | 2.27123954 |
| 74 | Split foot (HP:0001839) | 2.26970180 |
| 75 | Depression (HP:0000716) | 2.26540513 |
| 76 | Overriding aorta (HP:0002623) | 2.26225930 |
| 77 | Tetraplegia (HP:0002445) | 2.24914854 |
| 78 | Truncal ataxia (HP:0002078) | 2.24670306 |
| 79 | Infantile muscular hypotonia (HP:0008947) | 2.21591675 |
| 80 | Spastic tetraparesis (HP:0001285) | 2.19979683 |
| 81 | Hepatosplenomegaly (HP:0001433) | 2.19775101 |
| 82 | Hemorrhage of the eye (HP:0011885) | 2.19717990 |
| 83 | Broad face (HP:0000283) | 2.16785794 |
| 84 | Abnormal eating behavior (HP:0100738) | 2.15220085 |
| 85 | Hyperthyroidism (HP:0000836) | 2.15136349 |
| 86 | Esophageal atresia (HP:0002032) | 2.14513548 |
| 87 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.14117818 |
| 88 | White forelock (HP:0002211) | 2.12777143 |
| 89 | Hypomagnesemia (HP:0002917) | 2.12425362 |
| 90 | Apathy (HP:0000741) | 2.11905023 |
| 91 | Abnormality of the Achilles tendon (HP:0005109) | 2.11333495 |
| 92 | Patchy hypopigmentation of hair (HP:0011365) | 2.11088277 |
| 93 | Lower limb muscle weakness (HP:0007340) | 2.10649023 |
| 94 | Cupped ear (HP:0000378) | 2.10192089 |
| 95 | Fragile skin (HP:0001030) | 2.09690630 |
| 96 | * Sensory axonal neuropathy (HP:0003390) | 2.08255513 |
| 97 | Erythroderma (HP:0001019) | 2.06962712 |
| 98 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.06954863 |
| 99 | Aplasia of the phalanges of the hand (HP:0009802) | 2.06954863 |
| 100 | Aplasia involving bones of the extremities (HP:0009825) | 2.06954863 |
| 101 | Foot dorsiflexor weakness (HP:0009027) | 2.06396688 |
| 102 | Axonal loss (HP:0003447) | 2.05981632 |
| 103 | Metabolic alkalosis (HP:0200114) | 2.05714853 |
| 104 | Abnormality of the septum pellucidum (HP:0007375) | 2.04261843 |
| 105 | Anomalous pulmonary venous return (HP:0010772) | 2.03905666 |
| 106 | Hypoplasia of the iris (HP:0007676) | 2.03445577 |
| 107 | Neuroendocrine neoplasm (HP:0100634) | 2.02293187 |
| 108 | Megalencephaly (HP:0001355) | 2.02146205 |
| 109 | Clonus (HP:0002169) | 2.01551999 |
| 110 | Synostosis involving the elbow (HP:0003938) | 2.01138067 |
| 111 | Humeroradial synostosis (HP:0003041) | 2.01138067 |
| 112 | Renal Fanconi syndrome (HP:0001994) | 1.99261730 |
| 113 | Bowel incontinence (HP:0002607) | 1.98780920 |
| 114 | Generalized tonic-clonic seizures (HP:0002069) | 1.97444076 |
| 115 | Partial agenesis of the corpus callosum (HP:0001338) | 1.96769983 |
| 116 | Renovascular hypertension (HP:0100817) | 1.96473981 |
| 117 | Delusions (HP:0000746) | 1.95317340 |
| 118 | Diminished movement (HP:0002374) | 1.94293636 |
| 119 | Elfin facies (HP:0004428) | 1.93441987 |
| 120 | Truncus arteriosus (HP:0001660) | 1.93050435 |
| 121 | * Rigidity (HP:0002063) | 1.92449666 |
| 122 | Atonic seizures (HP:0010819) | 1.91471119 |
| 123 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.90326196 |
| 124 | Generalized myoclonic seizures (HP:0002123) | 1.89944528 |
| 125 | Hypokalemic alkalosis (HP:0001949) | 1.89661766 |
| 126 | Diminished motivation (HP:0000745) | 1.88902436 |
| 127 | Partial duplication of thumb phalanx (HP:0009944) | 1.88445540 |
| 128 | Relative macrocephaly (HP:0004482) | 1.87582654 |
| 129 | Renal duplication (HP:0000075) | 1.87518101 |
| 130 | Abnormality of the foot musculature (HP:0001436) | 1.86535720 |
| 131 | Increased connective tissue (HP:0009025) | 1.85871921 |
| 132 | Abnormal large intestine physiology (HP:0012700) | 1.85395799 |
| 133 | Muscle fiber splitting (HP:0003555) | 1.85018735 |
| 134 | Action tremor (HP:0002345) | 1.83725658 |
| 135 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.83465226 |
| 136 | Focal dystonia (HP:0004373) | 1.82336123 |
| 137 | Hammertoe (HP:0001765) | 1.81540909 |
| 138 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.80134082 |
| 139 | Pointed chin (HP:0000307) | 1.79443639 |
| 140 | Atrophic scars (HP:0001075) | 1.79370628 |
| 141 | Premature rupture of membranes (HP:0001788) | 1.78783642 |
| 142 | Adrenal hypoplasia (HP:0000835) | 1.77964038 |
| 143 | Polar cataract (HP:0010696) | 1.77401307 |
| 144 | Gowers sign (HP:0003391) | 1.77060593 |
| 145 | Steppage gait (HP:0003376) | 1.76143964 |
| 146 | Vaginal atresia (HP:0000148) | 1.75424141 |
| 147 | Bradykinesia (HP:0002067) | 1.75262907 |
| 148 | Hyperparathyroidism (HP:0000843) | 1.75078795 |
| 149 | Bladder diverticulum (HP:0000015) | 1.74585407 |
| 150 | Peripheral demyelination (HP:0011096) | 1.74505668 |
| 151 | Craniofacial dystonia (HP:0012179) | 1.73168371 |
| 152 | Abnormality of the pulmonary veins (HP:0011718) | 1.73124660 |
| 153 | * Distal sensory impairment (HP:0002936) | 1.72406360 |
| 154 | Chin dimple (HP:0010751) | 1.71511794 |
| 155 | Type II lissencephaly (HP:0007260) | 1.71452834 |
| 156 | Acanthosis nigricans (HP:0000956) | 1.70740365 |
| 157 | Loss of speech (HP:0002371) | 1.70299237 |
| 158 | Sleep apnea (HP:0010535) | 1.70081674 |
| 159 | Barrel-shaped chest (HP:0001552) | 1.69004126 |
| 160 | Abnormality of the salivary glands (HP:0010286) | 1.68805434 |
| 161 | Arnold-Chiari malformation (HP:0002308) | 1.68754011 |
| 162 | Abnormality of the lower motor neuron (HP:0002366) | 1.68737688 |
| 163 | Distal lower limb muscle weakness (HP:0009053) | 1.68167823 |
| 164 | Bowel diverticulosis (HP:0005222) | 1.67727019 |
| 165 | Cervical subluxation (HP:0003308) | 1.67481956 |
| 166 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.67432553 |
| 167 | * CNS hypomyelination (HP:0003429) | 1.66668296 |
| 168 | Myelomeningocele (HP:0002475) | 1.64302027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.60418253 |
| 2 | OXSR1 | 4.62131654 |
| 3 | SIK1 | 3.88786530 |
| 4 | EPHB1 | 3.54889759 |
| 5 | BCR | 2.88496094 |
| 6 | PKN1 | 2.74303134 |
| 7 | WNK4 | 2.72043533 |
| 8 | CDK19 | 2.71165021 |
| 9 | TNIK | 2.59691008 |
| 10 | EPHA2 | 2.50220037 |
| 11 | MET | 2.43815398 |
| 12 | TRIB3 | 2.43517735 |
| 13 | LMTK2 | 2.36652582 |
| 14 | PRKD3 | 2.32405634 |
| 15 | DAPK2 | 2.27131842 |
| 16 | PBK | 2.22762766 |
| 17 | NTRK3 | 2.17424172 |
| 18 | RIPK1 | 2.17078717 |
| 19 | IRAK3 | 2.14233351 |
| 20 | MAPKAPK5 | 2.12775884 |
| 21 | CAMKK1 | 2.08442740 |
| 22 | FGFR2 | 2.06003856 |
| 23 | WNK1 | 1.98625384 |
| 24 | UHMK1 | 1.96718327 |
| 25 | CSNK1G3 | 1.88946132 |
| 26 | LIMK1 | 1.82464979 |
| 27 | ICK | 1.77623584 |
| 28 | CSNK1A1L | 1.76757556 |
| 29 | NEK6 | 1.76447755 |
| 30 | PRPF4B | 1.73548035 |
| 31 | LATS2 | 1.73468881 |
| 32 | PNCK | 1.69232148 |
| 33 | MST1R | 1.67061422 |
| 34 | TESK1 | 1.64966023 |
| 35 | STK38 | 1.58681000 |
| 36 | ROCK2 | 1.57981749 |
| 37 | NTRK1 | 1.53534121 |
| 38 | CAMK2B | 1.50188895 |
| 39 | MST4 | 1.48842102 |
| 40 | CSNK1G1 | 1.46428515 |
| 41 | MAP3K11 | 1.46148319 |
| 42 | CLK1 | 1.45963788 |
| 43 | PAK6 | 1.43578779 |
| 44 | CSNK1G2 | 1.42844056 |
| 45 | FGR | 1.36085169 |
| 46 | DDR2 | 1.32831371 |
| 47 | EPHA4 | 1.28254277 |
| 48 | MINK1 | 1.27491532 |
| 49 | GRK5 | 1.26011771 |
| 50 | CAMK1 | 1.25653790 |
| 51 | CAMK2D | 1.23487306 |
| 52 | CAMKK2 | 1.21251338 |
| 53 | TESK2 | 1.18757632 |
| 54 | CASK | 1.17976309 |
| 55 | SGK223 | 1.13522001 |
| 56 | SGK494 | 1.13522001 |
| 57 | SIK2 | 1.09339611 |
| 58 | TYRO3 | 1.08652921 |
| 59 | DAPK1 | 1.04258840 |
| 60 | CAMK2G | 0.96813319 |
| 61 | MARK1 | 0.94647366 |
| 62 | PAK3 | 0.92338707 |
| 63 | MAP3K1 | 0.91359078 |
| 64 | PRKG2 | 0.90514670 |
| 65 | DYRK2 | 0.90403005 |
| 66 | MARK2 | 0.89808124 |
| 67 | CDK14 | 0.88273530 |
| 68 | ARAF | 0.88259295 |
| 69 | PDGFRA | 0.87799999 |
| 70 | MAPK15 | 0.83246411 |
| 71 | PRKCQ | 0.83192401 |
| 72 | CDK5 | 0.81169744 |
| 73 | IRAK2 | 0.77913066 |
| 74 | MUSK | 0.77785144 |
| 75 | CDK15 | 0.76035241 |
| 76 | TNK2 | 0.75357475 |
| 77 | CAMK2A | 0.74148880 |
| 78 | PRKD1 | 0.74102619 |
| 79 | PINK1 | 0.73490309 |
| 80 | MAP3K13 | 0.73142904 |
| 81 | PTK2 | 0.72556338 |
| 82 | PRKD2 | 0.70794832 |
| 83 | CDK18 | 0.70490710 |
| 84 | DYRK1B | 0.69403562 |
| 85 | TAOK2 | 0.68270577 |
| 86 | CDK11A | 0.67782306 |
| 87 | PDPK1 | 0.66069805 |
| 88 | PLK2 | 0.65310056 |
| 89 | CAMK1D | 0.65139479 |
| 90 | SGK3 | 0.64322096 |
| 91 | SMG1 | 0.62752136 |
| 92 | PRKCE | 0.62095776 |
| 93 | KSR2 | 0.61890024 |
| 94 | MAPK12 | 0.60869441 |
| 95 | FYN | 0.59900485 |
| 96 | IRAK1 | 0.57075255 |
| 97 | PHKG2 | 0.56973928 |
| 98 | PHKG1 | 0.56973928 |
| 99 | RIPK4 | 0.56783203 |
| 100 | ERN1 | 0.55512504 |
| 101 | MTOR | 0.53508407 |
| 102 | MAPK13 | 0.52330452 |
| 103 | ERBB4 | 0.52091821 |
| 104 | PRKCG | 0.51859142 |
| 105 | EEF2K | 0.50075833 |
| 106 | MAP3K6 | 0.49675642 |
| 107 | CSNK1D | 0.49666172 |
| 108 | RET | 0.48554756 |
| 109 | BRAF | 0.47660813 |
| 110 | MAP3K2 | 0.46656301 |
| 111 | ALK | 0.46074982 |
| 112 | NTRK2 | 0.45577607 |
| 113 | FGFR4 | 0.45087402 |
| 114 | RPS6KA5 | 0.44284429 |
| 115 | SGK2 | 0.43755127 |
| 116 | PRKG1 | 0.43457406 |
| 117 | CAMK4 | 0.43206074 |
| 118 | PRKCZ | 0.43015071 |
| 119 | STK11 | 0.42554335 |
| 120 | SGK1 | 0.42081735 |
| 121 | MAP2K2 | 0.40651589 |
| 122 | RPS6KA3 | 0.40651076 |
| 123 | RPS6KA2 | 0.40574110 |
| 124 | CSNK1A1 | 0.39903049 |
| 125 | PAK1 | 0.39215931 |
| 126 | PTK6 | 0.39148250 |
| 127 | FES | 0.38113110 |
| 128 | GSK3A | 0.35842889 |
| 129 | MAP3K9 | 0.35823033 |
| 130 | TRPM7 | 0.34639934 |
| 131 | BMX | 0.34201898 |
| 132 | BMPR1B | 0.32298834 |
| 133 | PDK1 | 0.32197852 |
| 134 | PRKACB | 0.31973640 |
| 135 | PRKCH | 0.31926113 |
| 136 | DAPK3 | 0.30522286 |
| 137 | PDGFRB | 0.28978102 |
| 138 | ROCK1 | 0.27862421 |
| 139 | PTK2B | 0.27457022 |
| 140 | MKNK1 | 0.26044938 |
| 141 | PRKACA | 0.25436808 |
| 142 | INSR | 0.25009287 |
| 143 | ADRBK2 | 0.24507216 |
| 144 | CSNK1E | 0.24397206 |
| 145 | MAPK10 | 0.23467057 |
| 146 | ITK | 0.22634492 |
| 147 | OBSCN | 0.21693247 |
| 148 | MAPK7 | 0.20743105 |
| 149 | DMPK | 0.20569253 |
| 150 | PIK3CA | 0.20283495 |
| 151 | DYRK1A | 0.20176737 |
| 152 | CAMK1G | 0.20161059 |
| 153 | GRK7 | 0.19934482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.65661935 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.89154903 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.55613581 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.58307583 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.01678710 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.75962522 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.64770505 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.61245418 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.52614642 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.04520735 |
| 11 | Axon guidance_Homo sapiens_hsa04360 | 1.97420700 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.97299259 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.94794185 |
| 14 | Protein export_Homo sapiens_hsa03060 | 1.90477141 |
| 15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.86333912 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.84740588 |
| 17 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.73325705 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.71940405 |
| 19 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.71629067 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59853200 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.59727350 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.51387357 |
| 23 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.47744905 |
| 24 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.44563018 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.42965247 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.38425279 |
| 27 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.36462122 |
| 28 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.35832068 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.35817510 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35540788 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.33380689 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32908091 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.31838428 |
| 34 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.29310031 |
| 35 | GABAergic synapse_Homo sapiens_hsa04727 | 1.28638398 |
| 36 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.27628343 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.26996413 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.26848624 |
| 39 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.17546037 |
| 40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.16334143 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.15499709 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.15042040 |
| 43 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.14063611 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10274556 |
| 45 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.04679388 |
| 46 | Long-term depression_Homo sapiens_hsa04730 | 1.04563848 |
| 47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.01498937 |
| 48 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01272535 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.00749683 |
| 50 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.99925745 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 0.96805417 |
| 52 | Morphine addiction_Homo sapiens_hsa05032 | 0.95706416 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94399050 |
| 54 | Tight junction_Homo sapiens_hsa04530 | 0.90758579 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90532234 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90203416 |
| 57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.89109135 |
| 58 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.88254860 |
| 59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.85457506 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84384340 |
| 61 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.83605718 |
| 62 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.83365487 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.83130236 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82483127 |
| 65 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.80135442 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.80119130 |
| 67 | Taste transduction_Homo sapiens_hsa04742 | 0.80100878 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78868236 |
| 69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77506259 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77138435 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.76672749 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76290157 |
| 73 | Cocaine addiction_Homo sapiens_hsa05030 | 0.75757797 |
| 74 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.74160812 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72876969 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71704858 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.70996846 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.70972407 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70840410 |
| 80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70604250 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70561507 |
| 82 | Circadian entrainment_Homo sapiens_hsa04713 | 0.70029074 |
| 83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69416906 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69175282 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67859604 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67788350 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67046540 |
| 88 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.66781593 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.66112159 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65856563 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.65057472 |
| 92 | Huntingtons disease_Homo sapiens_hsa05016 | 0.65044377 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.64968956 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.64628515 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64553030 |
| 96 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.64381347 |
| 97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64277016 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62890130 |
| 99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.62677640 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60439934 |
| 101 | Salivary secretion_Homo sapiens_hsa04970 | 0.59807936 |
| 102 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59399107 |
| 103 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.59060246 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59058303 |
| 105 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58725805 |
| 106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58633083 |
| 107 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57794737 |
| 108 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57581588 |
| 109 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.57275738 |
| 110 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.57208758 |
| 111 | Phototransduction_Homo sapiens_hsa04744 | 0.56753222 |
| 112 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55575406 |
| 113 | Peroxisome_Homo sapiens_hsa04146 | 0.53599850 |
| 114 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53144238 |
| 115 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.52169630 |
| 116 | Nicotine addiction_Homo sapiens_hsa05033 | 0.51780230 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51207154 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50740401 |
| 119 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.49516889 |
| 120 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49316854 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49282730 |
| 122 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49056885 |
| 123 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48800997 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.48195286 |
| 125 | Phagosome_Homo sapiens_hsa04145 | 0.46161948 |
| 126 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45221632 |
| 127 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43616495 |
| 128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42619363 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41879861 |
| 130 | Gap junction_Homo sapiens_hsa04540 | 0.41006825 |
| 131 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40125650 |
| 132 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.40066484 |
| 133 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37582042 |
| 134 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36648919 |
| 135 | Malaria_Homo sapiens_hsa05144 | 0.36633285 |
| 136 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34537784 |
| 137 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.34368349 |
| 138 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.33954579 |
| 139 | Renin secretion_Homo sapiens_hsa04924 | 0.33211760 |
| 140 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33022655 |
| 141 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31169501 |
| 142 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.28917822 |
| 143 | Alcoholism_Homo sapiens_hsa05034 | 0.26813542 |
| 144 | Prion diseases_Homo sapiens_hsa05020 | 0.26544133 |
| 145 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.25956703 |
| 146 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25790156 |
| 147 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.25448675 |
| 148 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.25238677 |
| 149 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.25169261 |
| 150 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24473406 |
| 151 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23071278 |
| 152 | ABC transporters_Homo sapiens_hsa02010 | 0.22260224 |

